Matthew S. Najor

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
A review of the literature finds that women diagnosed with breast cancer, who were on an aspirin regimen, experienced a decreased risk of distant metastases and death. Several recent studies have reported an improvement in overall survival in colorectal cancer patients who harbored mutations in the oncogene PIK3CA and received a daily aspirin regimen.(More)
  • 1